Response of patients with mild and moderate hemophilia A and von Willebrand's disease to treatment with desmopressin.
about
The use of desmopressin as a hemostatic agent: a concise reviewVon Willebrand disease: an overviewSignificant hyponatremia following DDAVP administration in a healthy adult.The use of desmopressin in von Willebrand disease: the experience of the first 30 years (1977-2007).Desmopressin and type II B von Willebrand disease.Severe hyponatremia after repeated intravenous administration of desmopressin.1-Desamino-8-arginine-vasopressin corrects the hemostatic defects in type 2B von Willebrand's disease.Desmopressin (DDAVP) in the treatment of bleeding disorders: the first twenty years.The use of desmopressin in acquired haemophilia A: a systematic review.Mild hemophilia A.The use of haemostatic drugs in haemophilia: desmopressin and antifibrinolytic agents.Congestive heart failure: potential role of arginine vasopressin antagonists in the therapy of heart failure.Effect of deamino-8-D-arginine desmopressin in uremic bleeding.Von Willebrand's disease: clinical management.Desmopressin for the treatment of haemophilia.von Willebrand disease (VWD): evidence-based diagnosis and management guidelines, the National Heart, Lung, and Blood Institute (NHLBI) Expert Panel report (USA).Reduced von Willebrand factor survival in von Willebrand disease: pathophysiologic and clinical relevance.Current options and new developments in the treatment of haemophilia.Clearance of von Willebrand factor.Desmopressin (DDAVP) in the management of patients with congenital bleeding disorders.An update on type 2B von Willebrand disease.Hyponatremia and seizures in young children given DDAVP.DDAVP in the treatment of bleeding disorders.Vasopressin analogues. Their role in disorders of hemostasis.Preoperative evaluation: the assessment and management of surgical risk.Molecular and phenotypic determinants of the response to desmopressin in adult patients with mild hemophilia A.Considerations for epidural anesthesia in a patient with type 1 von Willebrand disease.Lack of responsiveness to 1-desamino-D arginin vasopressin (desmopressin) in male patients with nephrogenic syndrome of inappropriate antidiuresis: from bench to bedside.DDAVP challenge tests in boys with mild/moderate haemophilia A.When a patient with a bleeding disorder needs dental work. How you can work with the dentist to prevent a crisis.Desmopressin response in hemophilia A patients with FVIII:C < 0.10 IU mL(-1.).Desmopressin in haemophilia: The need for a standardised clinical response and individualised test regimen.DDAVP responsiveness in children with mild or moderate haemophilia A correlates with age, endogenous FVIII:C level and with haemophilic genotype.Desmopressin (DDAVP) and hemostasis.Laboratory response to intranasal desmopressin in women with menorrhagia and platelet dysfunction.Patterns of development of tachyphylaxis in patients with haemophilia and von Willebrand disease after repeated doses of desmopressin (DDAVP).Donor reactions during DDAVP-stimulated plasmapheresis.Changes in factor VIII: coagulant activity and von Willebrand factor antigen concentration after subcutaneous injection of desmopressin in dogs with mild hemophilia A.DDAVP in acquired von Willebrand syndrome associated with multiple myeloma.Clinical efficacy of desmopressin acetate for hemostatic control in patients with primary platelet disorders undergoing surgery.
P2860
Q28210194-83DA8FF6-5C4B-4411-AADA-D0577311C73FQ28742241-31DE407D-07F0-4B32-B96F-2D5479D04810Q30467133-35F54327-1BD1-459F-9A7C-47743E736AB4Q33378140-39579279-558E-440C-8206-C143E2B6AB04Q33432439-CBF79470-B0A4-4B5D-B83F-21A730EDF8B0Q33439061-FA303CFF-8DFC-4C0B-9590-7BD28B73FE7CQ33495331-386807A4-B809-4814-8358-28410CCFD1A1Q34029483-0598D685-3CEB-41A0-86B1-116617E98D45Q34207741-7EFE02F5-6408-4E5F-B3D0-915567FF750DQ34614695-556759B1-A5C9-4850-84DB-9EF17134F5C1Q34636885-404EBFA8-8F7A-43FB-BEFE-9B78A0F030B8Q34943407-39E3ECC7-B17D-4982-9BE9-DEF7D1F7E8DBQ35938796-6AFBA098-BCCC-4B66-9A2D-9C62CE8CEB88Q36473103-25B48D82-F081-43F0-B92E-12EF13BB857BQ37049482-B063E445-5B72-47F9-A0A8-D1673BCDC15BQ37100261-A8230B2A-56D1-4B81-9590-B43191978140Q37561452-835D75C1-B23F-47F2-8CCE-96545C262D78Q37841547-2E055157-26A6-44BA-A1B9-4939B47A8A46Q38117738-C82F3936-E3A8-4787-885D-94415FCDDF1AQ38128397-3FAE0326-EC9B-401E-96C4-797C573CA5BEQ38187477-B6349F5A-30D4-4925-832E-732D291B9821Q38227774-BE7E5B70-11BF-4CC7-94C9-0A55D77F2AF9Q39511783-5AA47AFD-4D14-40D4-A7E7-9E20139B9790Q39599694-FED7E8F6-2F31-4DB4-8831-46DC384C61BDQ39663239-17286B76-421C-4766-AF0F-1D6E36789381Q42459194-B8C3FB89-D492-494F-8CDD-6F89BAE309ADQ43239922-54E1A2B1-E14A-40DB-9348-565BE417A09CQ43460589-378CCE01-3C30-44A6-B32F-5A1D4CDA671CQ44024550-BA371EED-F476-4DEF-8107-E18FB4A61239Q44580630-07300542-AB27-4208-84B4-C8552A05E2D8Q45861429-BBB83680-11CA-4EE1-A2C2-AFAF1A2E90BEQ45869060-3BB66B05-E246-4D31-B7FE-54B99B4333F4Q45870175-5233CC83-3B47-4BF3-91E0-7876F418A5F5Q45871084-76A413F8-4C24-4981-A68A-AADF91B0E7A3Q45875630-1B176764-3CA3-4428-A692-951389528200Q45879438-F884F0CA-1DD3-4CE9-A433-535A1A33707AQ45879513-B023559E-9ACC-4397-B04D-C260F52B5995Q45881542-B760B7B5-7488-497E-9FF1-F9204C5AE423Q45886916-762598CE-B85B-4765-87AF-0BDE6479E39FQ45887089-DD5C8CE1-DC50-413D-AEC4-B49F37270B12
P2860
Response of patients with mild and moderate hemophilia A and von Willebrand's disease to treatment with desmopressin.
description
1985 nî lūn-bûn
@nan
1985年の論文
@ja
1985年学术文章
@wuu
1985年学术文章
@zh
1985年学术文章
@zh-cn
1985年学术文章
@zh-hans
1985年学术文章
@zh-my
1985年学术文章
@zh-sg
1985年學術文章
@yue
1985年學術文章
@zh-hant
name
Response of patients with mild ...... o treatment with desmopressin.
@en
Response of patients with mild ...... o treatment with desmopressin.
@nl
type
label
Response of patients with mild ...... o treatment with desmopressin.
@en
Response of patients with mild ...... o treatment with desmopressin.
@nl
prefLabel
Response of patients with mild ...... o treatment with desmopressin.
@en
Response of patients with mild ...... o treatment with desmopressin.
@nl
P2093
P1476
Response of patients with mild ...... o treatment with desmopressin.
@en
P2093
Rickles FR
de la Fuente B
P356
10.7326/0003-4819-103-1-6
P407
P577
1985-07-01T00:00:00Z